RobiusUAE, UNFILTERED
Intelligence ↗Pulse
Skip to content
Sunday, 1 November 2026 Dubai · GST
UAE, UNFILTERED
AI
ROBIUS / AI ECOSYSTEM PROFILE

Vivan Therapeutics

Vivan Therapeutics

startuphub71-cohort-selectedFresh
Last independently checkedOctober 11, 2026Checked 20 days ago.
THE ROBIUS VIEW

Select assessment

Precision-medicine company using AI and proprietary data to support personalised cancer treatment direction.

DECISION BRIEF

What this record means

A concise reading of the structured evidence, written for practical decision-making.

01
Why it matters

Precision-medicine company using AI and proprietary data to support personalised cancer treatment direction.

02
Who can use or is affected

Selected for Hub71 Cohort 16 and participating in Abu Dhabi's technology ecosystem.

03
What to watch next

Hub71 cohort selection confirms ecosystem participation and company positioning, not independent validation of product performance, customer traction or regulatory status.

Evidence strengthNeeds review

Important evidence or freshness checks are incomplete.

Last checkedOctober 11, 2026
Next reviewNovember 1, 2026
EVIDENCE CHECK

How the assessment is supported

  • Primary evidence linked1 official source is attached.
  • Freshness checkChecked 20 days ago.
  • Editorial publication gateThis public version passed the system publication requirements.
  • Material changes preservedNo material update has been recorded after the baseline.
01

Primary sourceLinked evidence on hub71.com

02

Editorial checkReviewed October 11, 2026

03

Next triggerDeployment or programme status may change quickly

RELATIONSHIP INTELLIGENCE

How this record connects

Explore editorially mapped links, inbound connections and clearly labelled context derived from the published record.

No public relationships have been mapped yet.Robius will display connections here after an editor verifies and saves them.
ECOSYSTEM RECORD

What the evidence currently shows

verified

Primary emirate

Abu Dhabi

Primary sector

healthtech

AI focus areas

healthtech

What it actually does

Precision-medicine company using AI and proprietary data to support personalised cancer treatment direction.

Deployment status

hub71-cohort-selected

Confirmed deployment or availability

Hub71 selected Vivan Therapeutics for Cohort 16.

Named customers or public partners

Not disclosed in the cited Hub71 cohort source.

Funding or ownership

Private startup participating in Hub71 Cohort 16.

Who can access or use it

Selected for Hub71 Cohort 16 and participating in Abu Dhabi's technology ecosystem.

SOURCE RECORD

Official information

Official links let readers inspect the evidence directly. Marketing descriptions are not treated as proof of deployment, customers, performance, or availability.

Open official evidence ↗Open official website ↗
RELATED INTELLIGENCE

Records from the same Intelligence system with related context or a recent verification update.

SIDE-BY-SIDE

Compare intelligence records

Compare like-for-like fields within this Intelligence system. Empty fields remain clearly marked rather than guessed.

Choose a record to begin.The comparison will use the same structured fields that power the public profiles.
RECORD HISTORY

How this intelligence evolved

Material editorial changes are preserved so readers can see when and why the public record moved.

  1. Evidence review
    Source checked

    The supporting evidence was reviewed.

    Robius checked the linked primary source and preserved the current public assessment.

  2. Public baseline
    Published record

    The first verified public version was established.

    Later material edits appear above this baseline. Routine formatting changes are not shown.

Editorial and commercial disclosure

No commercial relationship is recorded for this profile. Commercial relationships cannot change the Robius assessment or omission of material limitations.